Indefinite Delivery Contract SPE2DX15D9355

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities and veterans' medical centers under the TRICARE West program. The contract has a total ceiling value of $4,999,999 and a period of performance through December 31, 2025. It enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables without any set-aside requirements. The task orders awarded to date, valued between $271 and $22,101, cover a variety of specialized pharmaceutical items, including oncology treatments, contraceptives, auto-injectors, and other medical supplies, to be delivered to the contractor's facility in Park Ridge, Illinois.

This IDC reinforces DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to secure direct awards from the DLA across multiple product categories. The contract provides the DLA with streamlined access to a diverse portfolio of critical medical items to fulfill the recurring supply needs of military healthcare sites under the TRICARE West program, demonstrating the contractor's capability to consistently meet the government's pharmaceutical requirements.